HAIP and ZenmuTech announced the launch of a joint cybersecurity business using communications defense technology. セグエグループ is behind this development. The stock is said to trade in a price range where 100 shares cost less than ¥100,000.
HAIP and ZenmuTech announced the launch of a new business related to medical AI platforms, using communications defense technology jointly developed and patented by the two companies. Following the announcement, ZenmuTech's stock was reportedly bid up to its daily limit at the time of reporting.
セグエグループ has had a long-standing technology, capital and business partnership with ZenmuTech, and has provided products incorporating secret-sharing technology through subsidiaries including ジェイズ・テクノロジー. In many cases, the minimum purchase price for 100 shares is now less than ¥100,000, which is said to be largely attributable to the impact of stock splits.
セグエグループ's business model is to deliver overseas manufacturers' products to government agencies and major corporations in Japan and build revenue through maintenance services. Its flagship RevoWorks has a certain share of the local-government market, but its performance may be affected by developments in Government Solution Service (GSS)-related projects promoted by the Digital Agency and by trends among overseas manufacturers, which have been identified as risks.
The focus going forward is whether the connection with HAIP and ZenmuTech will end as a publicity exercise or develop into a new core revenue stream. The sources of profit, how the business is structured, the status of order backlogs and advance payments, and the composition of gross profit will be key factors in assessing this.